These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5026347)

  • 21. Investigation and application of the USSR AMS live measles vaccine from the ESC strain for mass vacceination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):651-67. PubMed ID: 5400784
    [No Abstract]   [Full Text] [Related]  

  • 22. Mass measles vaccination: experience with live attenuated virus vaccine in and around Vellore.
    Benjamin V; Jadhav M; Roberts PO
    Indian Pediatr; 1969 Mar; 6(3):102-13. PubMed ID: 5784931
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vaccination against measles--adverse effects, cause of reduced protective effect in investigated material].
    Enell H; Simonsson H
    Lakartidningen; 1973 Sep; 70(39):3357-8. PubMed ID: 4788642
    [No Abstract]   [Full Text] [Related]  

  • 24. [On vaccination against measles with a live and attenuated virus (Schwarz strain) in a nursery school. Resistance to natural infection (author's transl)].
    Nardi G; Battistini A; Mazzeo G; Tanzi ML; Grzincich GL
    Ann Sclavo; 1977; 19(6):1144-52. PubMed ID: 618060
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vaccination against measles].
    Ek E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
    [No Abstract]   [Full Text] [Related]  

  • 26. [The anti-measles vaccination].
    Marchand JC
    Cah Med; 1970 Nov; 11(13):1105-8. PubMed ID: 5502818
    [No Abstract]   [Full Text] [Related]  

  • 27. [Measles and measles vaccination in Brazil. Magnitude of the problem and contribution to the method of small doses in mass immunization. Clinico-serological evaluation of 2 types of highly attenuated vaccine].
    Veronesi R; Penna HA; Issler H; Braga Nde P; de Carvalho PR; Oria H; Monetti V
    Hospital (Rio J); 1967 Oct; 72(4):1203-32. PubMed ID: 5306984
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-measles vaccination with inactivated virus].
    Terragna A; Roscioli B; De Marco B
    G Mal Infett Parassit; 1967 Apr; 19(4):219-22. PubMed ID: 5614197
    [No Abstract]   [Full Text] [Related]  

  • 29. [Apropos of measles vaccination. Results of the first trials of antimeasles vaccination in France with hyperattenuated living virus vaccine].
    Mande R; Jammet ML; Celers J; Boué A
    Ann Pediatr (Paris); 1967 Jan; 14(1):66-73. PubMed ID: 5597350
    [No Abstract]   [Full Text] [Related]  

  • 30. [Measles. 5 years' experience with the vaccination program in Chile].
    Borgoño JM; Greiber R
    Rev Med Chil; 1971 Jul; 99(7):500-6. PubMed ID: 5093511
    [No Abstract]   [Full Text] [Related]  

  • 31. A case control study to assess the efficacy of measles vaccine.
    Rajapaksa L
    Ceylon Med J; 1993 Dec; 38(4):178-80. PubMed ID: 8143333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of measles vaccination using the live measles virus vaccine SSW-L 16 on the complication rate in measles].
    Heidel G; Olbricht H; Ely K; Henkler J
    Z Arztl Fortbild (Jena); 1972 Feb; 66(3):171-4. PubMed ID: 5047088
    [No Abstract]   [Full Text] [Related]  

  • 33. [Trials of vaccination against measles with live and attenuated virus].
    Albano A; De Donato S; Nodari R; Criscuolo A
    G Mal Infett Parassit; 1967 Oct; 19(10):631-8. PubMed ID: 5611500
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimal age for vaccinating Zimbabwean children against measles. 1. Maternal and transplacentally transmitted measles antibodies in infancy.
    Mhere OT; Mhlanga GE; Spencer HR
    Cent Afr J Med; 1984 Oct; 30(10):187-9. PubMed ID: 6518490
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on measles in Thailand. V. Protection against a measles outbreak by previous vaccination in an isolated institution.
    Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S; Okuno Y
    Biken J; 1971 Dec; 14(4):413-7. PubMed ID: 5149999
    [No Abstract]   [Full Text] [Related]  

  • 36. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
    Ikić DM
    Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electroencephalographic and clinical observations in active measles vaccination with attenuated live vaccine].
    Müller K; Eckoldt G
    Dtsch Gesundheitsw; 1966 Jan; 21(2):70-6. PubMed ID: 5940860
    [No Abstract]   [Full Text] [Related]  

  • 39. [Is vaccination against measles justified?].
    Lerche C
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2435-8. PubMed ID: 4657021
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on measles in Thailand. 3. Field trials on measles vaccine.
    Tuchinda P; Sangkawibha N; Ueda S; Okuno Y; Bukkavesa S
    Biken J; 1968 Dec; 11(4):251-9. PubMed ID: 5721531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.